Confirming the role of the EGFR, Shuai and co-workers reported higher internalization of an anti-EGFR monoclonal antibody-conjugated nanoplatform in EGFR-positive human skin squamous cell carcinoma compared to EGFR-negative breast cancer [35]. Here, EGFR is linked to breast cancer.